SCHEMBL2192012

SCHEMBL2192012

Cc1cc(C(c2cc(C)c(O)cc2C)c2cc(C(C)(C)c3ccc(C(C)(c4cc(C)c(OCC(=O)O)c(C(c5cc(C)c(O)cc5C)c5cc(C)c(O)cc5C)c4)c4cc(C)c(OCC(=O)O)c(C(c5cc(C)c(O)cc5C)c5cc(C)c(O)cc5C)c4)cc3)cc(C)c2OCC(=O)O)c(C)cc1O

nearest known ligand 0.38

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
THRA P10827 2/20 0.38
THRB P10828 2/20 0.38
ESR1 P03372 3/20 0.35
ESR2 Q92731 1/20 0.35
CD69 Q07108 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ELANE P08246 1/20 0.34
PTPN1 P18031 5/20 0.33
PTPN2 P17706 3/20 0.33
PTPN6 P29350 3/20 0.33
CYP2C19 P33261 1/20 0.33
PPARD Q03181 1/20 0.32
PPARA Q07869 1/20 0.32
RORC P51449 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3452486 0.95 THRA (0.38) THRATHRBESR1ESR2CD69
SCHEMBL3452453 0.93 THRB (0.40) THRATHRBESR1ESR2CD69
SCHEMBL12258191 0.92 ESR1 (0.33) ESR1ESR2RORC
SCHEMBL3452257 0.91 ELANE (0.36) THRATHRBESR1ESR2CD69
SCHEMBL13400794 0.90 ESR1 (0.35) ESR1ESR2RORC
SCHEMBL3451321 0.87 THRA (0.41) THRATHRBESR1ESR2CD69
SCHEMBL3451941 0.87 THRA (0.39) THRATHRBESR1ESR2CD69
SCHEMBL3451489 0.86 PTGDR2 (0.42) THRATHRBCD69ELANE
SCHEMBL3452510 0.85 PTGDR2 (0.41) THRATHRBCD69ELANE
SCHEMBL3452356 0.84 RXRA (0.41) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9522868-B2 Tetrakis(ether-substituted formylphenyl) HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2016-12-20 US disclosed
US-20160016884-A1 NEW TETRAKIS(ETHER-SUBSTITUTED FORMYLPHENYL) HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2016-01-21 US disclosed
US-8017300-B2 Compound, positive resist composition and method for forming resist pattern TOKYO OHKA KOGYO CO., LTD. (JP) 2011-09-13 US disclosed
US-8017300-B2 Compound, positive resist composition and method for forming resist pattern TOKYO OHKA KOGYO CO., LTD. (JP) 2011-09-13 US disclosed
US-20110172457-A1 TETRAKIS(ETHER-SUBSTITUTED FORMYLPHENYL) AND NEW POLYNUCLEAR POLYPHENOL DERIVED FROM THE SAME HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2011-07-14 US disclosed
US-7858819-B2 Tris(formylphenyl) and novel polynuclear phenol derived therefrom HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2010-12-28 US disclosed
US-7858819-B2 Tris(formylphenyl) and novel polynuclear phenol derived therefrom HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2010-12-28 US disclosed
US-7858819-B2 Tris(formylphenyl) and novel polynuclear phenol derived therefrom HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2010-12-28 US disclosed
US-20100099908-A1 TRIS(FORMYLPHENYL) AND NEW POLYNUCLEAR POLYPHENOL DERIVED THEREFROM HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2010-04-22 US disclosed
US-20100099908-A1 TRIS(FORMYLPHENYL) AND NEW POLYNUCLEAR POLYPHENOL DERIVED THEREFROM HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2010-04-22 US disclosed
US-20100099908-A1 TRIS(FORMYLPHENYL) AND NEW POLYNUCLEAR POLYPHENOL DERIVED THEREFROM HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2010-04-22 US disclosed
US-20090202939-A1 COMPOUND, POSITIVE RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2009-08-13 US disclosed
US-20090202939-A1 COMPOUND, POSITIVE RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160016884-A1 NEW TETRAKIS(ETHER-SUBSTITUTED FORMYLPHENYL) AHR, PAH, ALK THRA 270/4885THRB 524/4885ESR1 502/4885
US-20090202939-A1 COMPOUND, POSITIVE RESIST COMPOSITION AND METHOD FOR FORMING RESIST PATTERN ACIN1, RER1, RRS1 THRA 1370/4885THRB 1589/4885ESR1 1138/4885
US-20110172457-A1 TETRAKIS(ETHER-SUBSTITUTED FORMYLPHENYL) AND NEW POLYNUCLEAR POLYPHENOL DERIVED FROM THE SAME AHR, PAH, ARNT THRA 1925/4885THRB 2189/4885ESR1 541/4885
US-20100099908-A1 TRIS(FORMYLPHENYL) AND NEW POLYNUCLEAR POLYPHENOL DERIVED THEREFROM AS3MT, RRM2, SHROOM3 THRA 1846/4885THRB 3036/4885ESR1 132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.